Dow Up1.13% Nasdaq Up1.41%

Abbott Laboratories (ABT)

43.59 Up 0.10(0.23%) 4:00PM EDT
|After Hours : 43.59 0.00 (0.00%) 4:30PM EDT
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Net Income 2,576,000   5,963,000   4,728,000  
Operating Activities, Cash Flows Provided By or Used In
Depreciation1,719,000  2,782,000  3,044,000  
Adjustments To Net Income266,000  2,428,000  1,197,000  
Changes In Accounts Receivables(113,000)36,000  (670,000)
Changes In Liabilities(1,101,000)(1,443,000)388,000  
Changes In Inventories(154,000)(417,000)(130,000)
Changes In Other Operating Activities131,000  (35,000)413,000  
Total Cash Flow From Operating Activities 3,324,000   9,314,000   8,970,000  
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(1,145,000)(1,795,000)(1,491,000)
Other Cash flows from Investing Activities(559,000)(703,000)1,613,000  
Total Cash Flows From Investing Activities (3,929,000) (5,560,000) 661,000  
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid(882,000)(3,183,000)(2,938,000)
Sale Purchase of Stock(1,210,000)(514,000)892,000  
Net Borrowings1,792,000  4,413,000  (3,977,000)
Other Cash Flows from Financing Activities(6,396,000)(521,000)(400,000)
Total Cash Flows From Financing Activities (6,696,000) 195,000   (6,423,000)
Effect Of Exchange Rate Changes(26,000)40,000  (43,000)
Change In Cash and Cash Equivalents (7,327,000) 3,989,000   3,165,000  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.